NO954511D0 - Nye krystallinske cefem-syreaddisjonssalter og fremgangsmåte for deres fremstilling - Google Patents

Nye krystallinske cefem-syreaddisjonssalter og fremgangsmåte for deres fremstilling

Info

Publication number
NO954511D0
NO954511D0 NO954511A NO954511A NO954511D0 NO 954511 D0 NO954511 D0 NO 954511D0 NO 954511 A NO954511 A NO 954511A NO 954511 A NO954511 A NO 954511A NO 954511 D0 NO954511 D0 NO 954511D0
Authority
NO
Norway
Prior art keywords
preparation
acid addition
addition salts
new crystalline
cephemic
Prior art date
Application number
NO954511A
Other languages
English (en)
Other versions
NO954511L (no
NO311891B1 (no
Inventor
Rudolf Lattrell
Walter Durckheimer
Peter Schmid
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of NO954511D0 publication Critical patent/NO954511D0/no
Publication of NO954511L publication Critical patent/NO954511L/no
Publication of NO311891B1 publication Critical patent/NO311891B1/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/207-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/247-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/48Methylene radicals, substituted by hetero rings
    • C07D501/56Methylene radicals, substituted by hetero rings with the 7-amino radical acylated by carboxylic acids containing hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO19954511A 1994-11-10 1995-11-09 Nye krystallinske cefem-syreaddisjonssalter og fremgangsmåte for deres fremstilling NO311891B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4440141A DE4440141A1 (de) 1994-11-10 1994-11-10 Neue kristalline Cephem-Säureadditionssalze und Verfahren zu ihrer Herstellung

Publications (3)

Publication Number Publication Date
NO954511D0 true NO954511D0 (no) 1995-11-09
NO954511L NO954511L (no) 1996-05-13
NO311891B1 NO311891B1 (no) 2002-02-11

Family

ID=6532953

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19954511A NO311891B1 (no) 1994-11-10 1995-11-09 Nye krystallinske cefem-syreaddisjonssalter og fremgangsmåte for deres fremstilling

Country Status (28)

Country Link
US (1) US5747484A (no)
EP (1) EP0711774B1 (no)
JP (1) JP3920939B2 (no)
KR (1) KR100449191B1 (no)
CN (1) CN1066452C (no)
AR (1) AR002246A1 (no)
AT (1) ATE213248T1 (no)
AU (1) AU707730B2 (no)
BR (1) BR9505132A (no)
CA (1) CA2162530C (no)
CZ (1) CZ290936B6 (no)
DE (2) DE4440141A1 (no)
DK (1) DK0711774T3 (no)
ES (1) ES2172549T3 (no)
FI (1) FI120263B (no)
HU (1) HU219475B (no)
IL (1) IL115914A (no)
MA (1) MA23709A1 (no)
NO (1) NO311891B1 (no)
NZ (1) NZ280424A (no)
OA (1) OA10242A (no)
PL (1) PL182806B1 (no)
PT (1) PT711774E (no)
RU (1) RU2161619C2 (no)
SK (1) SK282545B6 (no)
TR (1) TR199501392A2 (no)
TW (1) TW422847B (no)
ZA (1) ZA959510B (no)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998049130A2 (en) * 1997-04-29 1998-11-05 The University Of New Mexico Hydroxynaphthoic acids and derivatives
PT1558263E (pt) * 2002-10-25 2006-10-31 Intervet Int Bv Composicao farmaceutica de libertacao prolongada
JP5322649B2 (ja) * 2005-10-29 2013-10-23 インターベツト・インターナシヨナル・ベー・ベー セフキノム組成物およびその使用方法
TWI400243B (zh) * 2009-07-20 2013-07-01 Intervet Int Bv 製造西喹諾(cefquinome)粒子的方法
EP3616695A1 (en) 2011-09-09 2020-03-04 Merck Sharp & Dohme Corp. Methods for treating intrapulmonary infections
US20140234365A1 (en) * 2011-09-29 2014-08-21 Alere San Diego, Inc. 2-hydroxyhippuric acid analogs, and methods for their synthesis and use
US8809314B1 (en) 2012-09-07 2014-08-19 Cubist Pharmacueticals, Inc. Cephalosporin compound
US8476425B1 (en) 2012-09-27 2013-07-02 Cubist Pharmaceuticals, Inc. Tazobactam arginine compositions
CA2906151A1 (en) 2013-03-15 2014-09-18 Merck Sharp & Dohme Corp. Ceftolozane antibiotic compositions
US9872906B2 (en) 2013-03-15 2018-01-23 Merck Sharp & Dohme Corp. Ceftolozane antibiotic compositions
US20140274997A1 (en) 2013-03-15 2014-09-18 Cubist Pharmaceuticals, Inc. Cephalosporin pharmaceutical compositions
US10376496B2 (en) 2013-09-09 2019-08-13 Merck, Sharp & Dohme Corp. Treating infections with ceftolozane/tazobactam in subjects having impaired renal function
US20150094293A1 (en) 2013-09-27 2015-04-02 Calixa Therapeutics, Inc. Solid forms of ceftolozane

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3118732A1 (de) * 1981-05-12 1982-12-02 Hoechst Ag, 6000 Frankfurt Cephalosporinderivate und verfahren zu ihrer herstellung
DE3248281A1 (de) * 1982-12-28 1984-06-28 Hoechst Ag, 6230 Frankfurt Kristalisierte cephem-saeureadditionssalze und verfahren zu ihrer herstellung
DE3316797A1 (de) * 1983-05-07 1984-11-08 Hoechst Ag, 6230 Frankfurt Verfahren zur herstellung von cephemverbindungen
DE3706020A1 (de) * 1987-02-25 1988-09-08 Hoechst Ag Kristallisierte cephem-saeureadditionssalze und verfahren zu ihrer herstellung

Also Published As

Publication number Publication date
NZ280424A (en) 1997-06-24
TR199501392A2 (tr) 1996-07-21
AU3772895A (en) 1996-05-16
EP0711774B1 (de) 2002-02-13
SK282545B6 (sk) 2002-10-08
OA10242A (fr) 1997-09-19
HU219475B (hu) 2001-04-28
CA2162530C (en) 2007-07-31
DE59510048D1 (de) 2002-03-21
DK0711774T3 (da) 2002-04-22
MA23709A1 (fr) 1996-07-01
CA2162530A1 (en) 1996-05-11
CZ290936B6 (cs) 2002-11-13
ES2172549T3 (es) 2002-10-01
KR960017670A (ko) 1996-06-17
HUT74163A (en) 1996-11-28
NO954511L (no) 1996-05-13
FI120263B (fi) 2009-08-31
CN1129220A (zh) 1996-08-21
FI955382A0 (fi) 1995-11-08
JPH08208662A (ja) 1996-08-13
RU2161619C2 (ru) 2001-01-10
IL115914A (en) 2002-08-14
PL311326A1 (en) 1996-05-13
EP0711774A1 (de) 1996-05-15
TW422847B (en) 2001-02-21
ZA959510B (en) 1996-05-28
NO311891B1 (no) 2002-02-11
HU9503213D0 (en) 1996-01-29
PT711774E (pt) 2002-07-31
CZ293395A3 (en) 1996-05-15
CN1066452C (zh) 2001-05-30
DE4440141A1 (de) 1996-05-15
JP3920939B2 (ja) 2007-05-30
KR100449191B1 (ko) 2006-01-12
AR002246A1 (es) 1998-03-11
US5747484A (en) 1998-05-05
IL115914A0 (en) 1996-01-31
BR9505132A (pt) 1997-09-09
ATE213248T1 (de) 2002-02-15
AU707730B2 (en) 1999-07-15
FI955382A (fi) 1996-05-11
PL182806B1 (pl) 2002-03-29
SK139795A3 (en) 1996-06-05

Similar Documents

Publication Publication Date Title
NO963499D0 (no) Hydroksaminsyre- og karboksylsyrederivater, fremgangsmåte for deres fremstilling og anvendelse derav
NO991761D0 (no) Nye piperidin-kotokarbonsyre-derivater, deres fremstilling og anvendelse
NO179485C (no) Krystallinske (metallo)silikater og -germanater, SUZ-4, fremgangsmåte for deres fremstilling og anvendelse derav
NO954511L (no) Nye krystallinske cefem-syreaddisjonssalter og fremgangsmåte for deres fremstilling
NO892745D0 (no) Aminoalkylaminokarbonylaminodiolaminosyrederivater og fremgangsmaate for deres fremstilling.
DK0734382T3 (da) Krystallinske N-acetyl-neuraminsyrederivater og fremgangsmåder til deres fremstilling
NO834824L (no) Krystalliserte cefem-syreaddisjonssalter og fremgangsmaate til deres fremstilling
DK406987D0 (da) Nye bisfosfonsyrederivater, deres fremstilling og brug
NO943794D0 (no) 4-difenylmethylpiperidinderivater, og fremgangsmåte for deres fremstilling
NO995909L (no) Krystallinske makrolider og fremgangsmåte for deres fremstilling
NO893886D0 (no) Nye aminokinolinforbindelser og fremgangsmaate for deres fremstilling.
NO914288L (no) Nye 2-sakkarinylmetylarylkarboksylater og fremgangsmaater for deres fremstilling
NO974513D0 (no) Pyrrolidinyl-hydroksamsyre-forbindelser og deres fremgangsmåte for fremstilling
NO984714D0 (no) Nye karboksylsyre-derivater, deres fremstilling og anvendelse
NO924479D0 (no) Nye aminoalkanfosfinsyrer og deres salter
NO880811D0 (no) Krystalliserte cefem-syreaddisjonssalter og fremgangsmaate til deres fremstilling.
NO984713L (no) Nye karboksylsyre-derivater, deres fremstilling og anvendelse
MA22401A1 (fr) Procede de preparation de sels de guinoleine
DK491385A (da) 1,2,4-triazolocarbamater og deres syreadditionssalte, fremgangsmaader til deres fremstilling og laegemidler indeholdende saadanne forbindelser
FI962880A0 (fi) Menetelmä ja välituotteita naftyridonikarboksyylihapposuolojen valmistusta varten
NO930816D0 (no) Nye aminokarboksylsyrederivater med antiallergisk/antiastmatisk virkning og fremgangsmaate for deres fremstilling
NO865004D0 (no) Nye 16,17-acetalsubstituerte pregnan-21-oinsyre-derivater og fremgangsmaate for deres fremstilling.
NO993076L (no) Fremgangsmåte for krystallisering av et tetrahydro-pyridinderivat og resulterende krystallinske former
DK30586D0 (da) N-substituerede 2-chlor-7-fluor-10-piperzino-10,11-dihydrodibenzo(b,f)thiepiner, deres syreadditionssalte og fremgangsmaader til deres fremstilling
NO955325L (no) Propansyrederivater, deres fremstilling og terapeutiske anvendelse

Legal Events

Date Code Title Description
MK1K Patent expired